AzTrials
AzTrials

Anomia (Word-Finding Impairment)NCT06619756

Anomia Treatment Predictors

A study testing Phonomotor Treatment (PMT) and Phonological Components Analysis (PCA) in people with Anomia (Word-Finding Impairment) and Aphasia, run by State University of New York at Buffalo at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to identify predictors of response to phonological-focused anomia treatment in people with aphasia. The main question it aims to answer is who responds to which type of anomia treatment. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anomia (Word-Finding Impairment), Aphasia
What is being tested?
Phonomotor Treatment (PMT) and Phonological Components Analysis (PCA)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2 participants
Where
1 siteUnited States
Study dates
18 Sep 2024to 1 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Chronic aphasia (6+ months)
  • Anomia
  • Sufficient auditory comprehension to follow task instructions
  • Phonologic impairment

Who cannot join

  • Progressive neurological illness or disease, including dementia
  • Chronic medical illness that interferes with adherence to testing schedule
  • Severe, uncorrected vision or hearing impairment that interferes with task completion
  • Moderate-severe apraxia of speech or dysarthria that interferes with task completion

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UB Audiology and Speech-Language Pathology Clinic

    Buffalo, New York, 14214

Other trials in United States

About this study

Official title: Predictors of Phonological-focused Anomia Treatment

The goal of this clinical trial is to identify predictors of response to phonological-focused anomia treatment in people with aphasia. The main question it aims to answer is who responds to which type of anomia treatment. Researchers will compare Phonomotor Treatment and Phonological Components Analysis to see which treatment is more beneficial, and for whom. Participants will engage in both treatments over several months.

Read the detailed description

Participants will complete screening and characterization testing to determine eligibility for the study. Each treatment will be administered twice a week, for 10-15 sessions. Pre-treatment and post-treatment testing will also occur for each treatment. There will be a period of no treatment in between the first and second treatment blocks.

Being tested
Phonomotor Treatment (PMT), Phonological Components Analysis (PCA)
Keywords
anomia treatment, aphasia treatment
Medical subject headings
Anomia, Aphasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Phonomotor Treatment (PMT)Behavioural

    Anomia treatment focuses on improving word-finding abilities. This intervention targets the phonology of words to improve word-finding.

  • Phonological Components Analysis (PCA)Behavioural

    Anomia treatment focuses on improving word-finding abilities. This intervention targets the phonology of words to improve word-finding.

Study groups in NCT06619756
Study groupRoleWhat they receive
PMTExperimentalPhonomotor Treatment (PMT) will be administered. This treatment improves anomia by training the sound sequences of words. This is a multimodal treatment approach that includes listening, producing, visualizing, and describing sounds and sound sequences. The participant practices the sound sequence tasks with the clinician.
Receives: Behavioral: Phonomotor Treatment (PMT)
PCAExperimentalPhonological Components Analysis (PCA) will be administered. This treatment improves anomia by identifying phonological features of words. A picture is presented. The participant provides features of the picture name: the first sound of the word, the final sound of the word, the number of syllables of the word, another word that starts with the same sound, and another words that rhymes with the word. The participant attempts to produce the word independently and by repeating after the clinician.
Receives: Behavioral: Phonological Components Analysis (PCA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Naming of Trained Words

    Picture naming of trained words

    Measured: Pre-treatment and Immediately post-treatment

Secondary outcomes (3)
  1. Naming of Untrained Words

    Picture naming of untrained words

    Measured: Pre-treatment and Immediately post-treatment

  2. Standardized Assessment of Phonology in Aphasia (SAPA)

    The SAPA assesses phonological processing abilities, including oral reading, rhyme judgments, minimal pair judgments, lexical decision, blending, and parsing.

    Measured: Pre-treatment and Immediately post-treatment

  3. Philadelphia Naming Test

    The short-form of the Philadelphia Naming Test is a picture naming test of items not seen during treatment.

    Measured: Pre-treatment and Immediately post-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2024
  2. Study start18 Sep 2024
  3. Primary completion1 Oct 2025
  4. Study completion1 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06619756
Sponsor's protocol ID
STUDY00008623
Status last verified
Nov 2025
First submitted
27 Sep 2024
Last updated
12 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Sample size is low increasing risk of identification of individuals.

Questions about this trial

What is this clinical trial studying?

A study testing Phonomotor Treatment (PMT) and Phonological Components Analysis (PCA) in people with Anomia (Word-Finding Impairment) and Aphasia, run by State University of New York at Buffalo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Naming of Trained Words (time frame: Pre-treatment and Immediately post-treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in